CFDE Data Portal | Search OR6E1P

	Label	Description
	OR6E1P Gene (Entity type)	ENSG00000235213 - olfactory receptor family 6 subfamily E member 1 pseudogene
	GSE202434 GSE202438 talazoparib 6 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 6 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155987 LMTK2 knockdown CFBE41o- 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GPR75 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	TAS2R13 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GTEx Bladder 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Thyroid 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx SalivaryGland 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx

OR6E1P

ENSG00000235213 - olfactory receptor family 6 subfamily E member 1 pseudogene

GSE202434 GSE202438 talazoparib 6 v 14 human dn

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 6 v 1 human dn

A Gene Set from LINCS

GSE155987 LMTK2 knockdown CFBE41o- 0 v 3 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 2 v 4 human up

A Gene Set from LINCS

GPR75 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

TAS2R13 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GTEx Bladder 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Thyroid 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx SalivaryGland 20-29 vs 40-49 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.